Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$40.25 - $52.99 $982,220 - $1.29 Million
24,403 Added 188.02%
37,382 $1.55 Million
Q1 2024

May 10, 2024

SELL
$47.98 - $54.4 $256,261 - $290,550
-5,341 Reduced 29.15%
12,979 $703,000
Q4 2023

Feb 13, 2024

SELL
$48.48 - $57.85 $842,679 - $1.01 Million
-17,382 Reduced 48.69%
18,320 $939,000
Q3 2023

Nov 08, 2023

BUY
$57.89 - $64.73 $1.67 Million - $1.87 Million
28,823 Added 419.0%
35,702 $2.07 Million
Q2 2023

Aug 11, 2023

BUY
$63.71 - $70.74 $155,452 - $172,605
2,440 Added 54.97%
6,879 $439,000
Q1 2023

May 11, 2023

SELL
$65.71 - $74.53 $520,883 - $590,799
-7,927 Reduced 64.1%
4,439 $307,000
Q4 2022

Feb 14, 2023

SELL
$68.48 - $81.09 $344,317 - $407,720
-5,028 Reduced 28.91%
12,366 $889,000
Q3 2022

Nov 14, 2022

BUY
$0.13 - $76.84 $816 - $482,401
6,278 Added 56.48%
17,394 $1.24 Million
Q2 2022

Aug 09, 2022

BUY
$72.62 - $79.98 $603,835 - $665,033
8,315 Added 296.86%
11,116 $856,000
Q1 2022

May 09, 2022

SELL
$61.48 - $73.72 $129,046 - $154,738
-2,099 Reduced 42.84%
2,801 $205,000
Q4 2021

Feb 10, 2022

BUY
$53.63 - $62.52 $262,787 - $306,348
4,900 New
4,900 $306,000
Q2 2021

Aug 11, 2021

SELL
$61.91 - $67.42 $759,264 - $826,838
-12,264 Closed
0 $0
Q1 2021

May 14, 2021

BUY
$59.34 - $66.74 $727,745 - $818,499
12,264 New
12,264 $774,000
Q4 2019

Jan 23, 2020

SELL
$49.21 - $64.19 $425,961 - $555,628
-8,656 Closed
0 $0
Q3 2019

Oct 16, 2019

BUY
$42.77 - $50.71 $370,217 - $438,945
8,656 New
8,656 $439,000
Q4 2018

Feb 08, 2019

SELL
$48.76 - $63.23 $271,934 - $352,633
-5,577 Closed
0 $0
Q3 2018

Nov 08, 2018

BUY
$55.19 - $62.25 $307,794 - $347,168
5,577 New
5,577 $346,000
Q1 2018

May 04, 2018

SELL
$59.92 - $68.98 $247,529 - $284,956
-4,131 Closed
0 $0
Q4 2017

Feb 14, 2018

BUY
$59.94 - $65.35 $247,612 - $269,960
4,131
4,131 $253,000

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $124B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Campbell & CO Investment Adviser LLC Portfolio

Follow Campbell & CO Investment Adviser LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Campbell & CO Investment Adviser LLC, based on Form 13F filings with the SEC.

News

Stay updated on Campbell & CO Investment Adviser LLC with notifications on news.